Skip to main content
Clinical Trials/IRCT20180102038195N1
IRCT20180102038195N1
Completed
未知

Safety evaluation of amniotic membrane extract in management of the diabetic foot ulcers

Iranian academic center for education culture and research0 sites10 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Iranian academic center for education culture and research
Enrollment
10
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Iranian academic center for education culture and research

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • To be able and willing to provide consent letter and agree to comply with study procedures and follow\-up evaluations
  • Ulcer size\>1 and \<36 cm2
  • Ulcer duration of \=4weeks
  • No clinical signs of infection
  • Serum creatinine\<3·0 mg/dl
  • Glycosylated haemoglobin (HbA1c)\<12%
  • Adequate circulation
  • Ankle\-brachial index (ABI) between 0·7 and 1·2 or having e a normal Doppler arterial

Exclusion Criteria

  • participating in another clinical trial
  • Currently receiving radiation or chemotherapy
  • known or suspected malignancy of current ulcer
  • Diagnosis of autoimmune connective tissue disease
  • Received a biomedical or topical growth factor for their wound within the previous 30 days
  • Pregnant or breast feeding
  • Sensitivity to drug uses
  • Smoking and drug abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials